Skip to content

Drug: Adezunap (AP707): chronic pain clinical trials

Registry records that list "Drug: Adezunap (AP707)" as an intervention. Being studied does not mean an intervention works or is approved.
0
Trials with Canadian sites
0
Recruiting in Canada
7
Registry records in total

Trials in Canada

No trial with a Canadian site lists this intervention in this snapshot.

Trials worldwide (outside Canada)

7 trials, 0 recruiting or not yet recruiting. Recruiting first.

PhaseCountries
Efficacy and Tolerability of AP707 in Patients With Chronic Pain Due to Traumatic or Post-operative Peripheral Neuropathy
NCT06071936
Unknown statusPhase 3GermanyApurano Pharmaceuticals GmbH2023-11-02
Long Term Efficacy and Tolerability of AP707 in Patients With Chronic Back Pain
NCT06071962
Unknown statusPhase 3GermanyApurano Pharmaceuticals GmbH2023-11-02
Long Term Efficacy and Tolerability of AP707 in Patients With Chronic Pain Due to Diabetic Polyneuropathy
NCT06071975
Unknown statusPhase 3GermanyApurano Pharmaceuticals GmbH2023-11-02
Long Term Efficacy and Tolerability of AP707 in Patients With Chronic Pain Due to Traumatic or Post-operative Peripheral Neuropathy
NCT06071988
Unknown statusPhase 3GermanyApurano Pharmaceuticals GmbH2023-11-02
Long Term Efficacy and Tolerability of AP707 in Patients With Chronic Pain Due to Central Neuropathy of Any Genesis
NCT06072001
Unknown statusPhase 3GermanyApurano Pharmaceuticals GmbH2023-11-02
Efficacy and Tolerability of AP707 in Patients With Chronic Back Pain
NCT06072560
Unknown statusPhase 3GermanyApurano Pharmaceuticals GmbH2023-11-02
Efficacy and Tolerability of AP707 in Patients With Chronic Pain Due to Diabetic Polyneuropathy
NCT06072573
Unknown statusPhase 3GermanyApurano Pharmaceuticals GmbH2023-11-02

Conditions studied with this intervention

Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status.